Verified Nov 2026
Other
·

London, England
·
Since 1993
Hammersmith Medicines Research is a contract research organisation headquartered in London, England, founded in 1993. The privately held company employs 200–500 staff and operates as early-phase clinical trial provider in the UK. It serves pharmaceutical and biotechnology companies across automotive, electric-vehicle, and medical industries, having completed over 900 studies since inception. In August 2025, Nucleus Network acquired HMR, integrating it into a global network of early-phase trial units.
Hammersmith Medicines Research at a glance
Revenue
$10-50M
Est. band
Employees
200-500
Founded
1993
Headquarters
London, England
Certifications
ISO 9001
Industries
Automotive
Electric Vehicles
Medical
STABILITY SIGNALS
Established & active
33 years in operation (founded 1993).
Holds ISO 9001 certification(s) per public sources.
Overview
Hammersmith Medicines Research is a contract research organisation headquartered in London, England, founded in 1993. The privately held company employs 200–500 staff and operates as early-phase clinical trial provider in the UK. It serves pharmaceutical and biotechnology companies across automotive, electric-vehicle, and medical industries, having completed over 900 studies since inception. In August 2025, Nucleus Network acquired HMR, integrating it into a global network of early-phase trial units.
At a glance
Attribute | Detail |
|---|---|
Founded | 1993 |
Headquarters | London, England |
Employees | 200-500 |
Revenue | $10-50M (estimated) |
Certifications | ISO 9001 |
What Hammersmith Medicines Research makes
The company conducts Phase 1 and early Phase 2 studies, including pharmacokinetic and pharmacodynamic assessments, drug interaction trials, sleep studies, and first-in-human investigations, with onsite investigational medicinal product manufacturing.
Certifications
Hammersmith Medicines Research is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 9001 — cornisharchitects.com
Latest developments
2026-07-23 — We’re delighted to share that we recently completed our Site Initiation Visit (SIV) at Hammersmith Medicines Research in London, marking the official start of our Phase 1 healthy volunteer clinical trial of … | Pangea Bio (linkedin.com)
2026-04-08 — We are proud to announce that our London site, Hammersmith Medicines Research Ltd, has been certified as a Clario Certified Site Partner, joining a global network of high-performing research sites recognised for … | Hammersmith Medicines Research Ltd (linkedin.com)
2025-08-04 — Nucleus Network Acquires Hammersmith Medicines Research | Nucleus Network (nucleusnetwork.com)
2025-08-04 — Nucleus Network Acquires Hammersmith Medicines Research - LevinPro Healthcare M&A – The latest healthcare M&A news (levinassociates.com)
2025-08-04 — We’re proud to announce the acquisition of Hammersmith Medicines Research. (linkedin.com)
Facilities
Hammersmith Medicines Research is headquartered in London, England. Public sources also reference these locations:
Australia — levinassociates.com
Company details
HMR holds ISO 9001 certification and achieved Clario Certified Site Partner status in April 2026, recognised for performance standards within a global network of research sites. Hammersmith Medicines Research was founded in 1993, has an estimated 200-500 employees, and is headquartered in London, England. On the LightSource stability read it is rated "Established & active": 33 years in operation (founded 1993). Holds ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Hammersmith Medicines Research do?
Hammersmith Medicines Research is a contract research organisation headquartered in London, England, founded in 1993. The privately held company employs 200–500 staff and operates as early-phase clinical trial provider in the UK. It serves pharmaceutical and biotechnology companies across automotive, electric-vehicle, and medical industries, having completed over 900 studies since inception. In August 2025, Nucleus Network acquired HMR, integrating it into a global network of early-phase trial units.
Where is Hammersmith Medicines Research headquartered?
Hammersmith Medicines Research is headquartered in London, England (131 Scrubs Lane, London, England, NW10 6).
When was Hammersmith Medicines Research founded?
Hammersmith Medicines Research was founded in 1993.
How big is Hammersmith Medicines Research?
Hammersmith Medicines Research has an estimated 200-500 employees, with revenue in the $10-50M range (estimated).
What certifications does Hammersmith Medicines Research hold?
Hammersmith Medicines Research lists ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
